The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer

Keyphrases

• Prostate Cancer 100%
• Dihydropyrimidine Dehydrogenase 100%
• 5-fluorouracil (5-FU) 66%
• 5-chloro-2 41%
• Dihydroxypyridine 41%
• Prostate Tissue 33%
• Normal Prostate 25%
• DU145 25%
• Tegafur 25%
• Tumor 16%
• Radical Prostatectomy 16%
• Cytotoxicity 16%
• Neoadjuvant Endocrine Therapy 16%
• Prognostic Significance 8%
• No Recurrence 8%
• LNCaP 8%
• Cancer Tissue 8%
• Human Prostate Cancer Cell Lines 8%
• Immunohistochemistry 8%
• Metabolism 8%
• Oral Administration 8%
• Cancer Cell Lines 8%
• Antitumor Activity 8%
• Potent Inhibitor 8%
• Prodrug 8%
• 5-year Follow-up 8%
• Immunodeficient Mice 8%
• Patient Materials 8%
• Recurrence-free Survival 8%
• Tissue Specimens 8%
• In Vivo Applications 8%
• Antitumoral Activity 8%
• Positive Expression 8%

Medicine and Dentistry

• Prostate Cancer 100%
• Dihydropyrimidine Dehydrogenase 100%
• Fluorouracil 83%
• Gimeracil 41%
• Prostate Tissue 33%
• Tegafur 25%
• Neoplasm 16%
• Prostatectomy 16%
• Cytotoxicity 16%
• Hormone Therapy 16%
• Recurrent Disease 8%
• In Vitro 8%
• Prostate Cancer Cell Line 8%
• Immunohistochemistry 8%
• Recurrence Free Survival 8%
• Antineoplastic Activity 8%
• Oral Drug Administration 8%
• Prodrug 8%
• Oxidoreductase Inhibitor 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Gimeracil 41%